Litcius/Paper detail

PD-1/PD-L1 Inhibitors in Combination With Chemo or as Monotherapy vs. Chemotherapy Alone in Advanced, Unresectable HER2-Negative Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Meta-Analysis

Mohammed S. Beshr, Ibrahem A Beshr, Mohammad Al Hayek, Sarah Mohamed Alfaqaih, M. Abuajamieh, Eman Basheer, A. Wali, Moad Ekreer, Imane Chenfouh, Ali S. Khashan, EssamA Hassan, S M Elnaami, Muhammed Elhadi

2024Clinical Oncology17 citationsDOIOpen Access PDF

Topics & Concepts

MedicineEsophageal adenocarcinomaGastroesophageal JunctionInternal medicineChemotherapyMeta-analysisOncologyGastroenterologyAdenocarcinomaCombination chemotherapyCancerCancer Immunotherapy and BiomarkersEsophageal Cancer Research and TreatmentGastric Cancer Management and Outcomes
PD-1/PD-L1 Inhibitors in Combination With Chemo or as Monotherapy vs. Chemotherapy Alone in Advanced, Unresectable HER2-Negative Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Meta-Analysis | Litcius